Cathy Friedman
CIK 1411874 · last filed 2026-06-12
Cathy Friedman is a corporate insider who has filed 50 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for LYEL, was dated Jun 12, 2026. Across all open-market trades the lifetime net is +$398.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.9M across reported positions. 9 SEC filings were submitted jointly with Innoviva, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
Filer Profile
1600 AMPHITHEATRE PKWY
MOUNTAIN VIEW, CA 94043
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LYEL | Director | 5,000 | $9.26 | $46.3K | $300.0K | 8 | 2026-06-12 |
| SEER | Director | 173,574 | $2.25 | $390.5K | $0 | 4 | 2023-06-16 |
| Radius Health, Inc. (RDUS) Delisted | Director | 0 | $30.00 | $0 | $0 | 12 | 2022-08-15 |
| INVA | Director | 73,805 | $20.50 | $1.51M | $0 | 2 | 2017-04-24 |
| XENOPORT INC (XNPT) Delisted | Director | 0 | — | — | $98.3K | 11 | 2016-07-06 |
| ReShape Weightloss Inc. (ETRM) Delisted | Director | 13,800 | — | — | $0 | 8 | 2015-05-08 |
| Innoviva, Inc. (THRX) Delisted | Director | 35,620 | $4.06 | $144.6K | $0 | 2 | 2015-04-27 |
Recent Filings
50 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-12 | LYEL | Grant (A) | — | $0 | EDGAR |
| 2025-05-19 | LYEL | Grant (A) | — | $0 | EDGAR |
| 2024-06-17 | LYEL | Grant (A) | — | $0 | EDGAR |
| 2023-09-08 | LYEL | Grant (A) | — | $0 | EDGAR |
| 2023-06-20 | LYEL | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | SEER | Grant (A) | +23,443 | $0 | EDGAR |
| 2022-08-15 | Radius Health, Inc. (RDUS) Delisted | Disp (D) | −26,800 | -$268.0K | EDGAR |
| 2022-06-17 | SEER | Grant (A) | +9,945 | $0 | EDGAR |
| 2022-06-10 | LYEL | Grant (A) | — | $0 | EDGAR |
| 2022-01-25 | Radius Health, Inc. (RDUS) Delisted | Grant (A) | +5,500 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.